Flow Cytometry Market Expected to Reach $10.4 Billion by 2031

Flow cytometry market size was valued at $4.7 billion in 2021, and is estimated to reach $10.4 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031. Flow cytometry is a biophysical, laser-based analytical technology, which is used to measure and analyze cells in a fluid system. Cells under analysis are labelled using fluorescent techniques and then excited using laser to emit light at different wavelengths to analyze characteristics of cells or particles. During the process, a sample of cells or particles is suspended in fluid and injected into a flow cytometer machine. Approximately 10,000 cells can be analyzed and processed by a computer in less than one minute.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Thermo Fisher Scientific Inc., bioMérieux SA, Danaher Corporation, Miltenyi Biotec, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Sysmex Corporation, Sartorius AG, Becton Dickinson and Company

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/90

On the basis of component, the flow cytometry market analysis showed that the instruments segment accounted for the highest market share in 2021, owing to development of novel instrument designs, demand for highly efficient replaceable components, applications in treatment of newer diseases, and increase in research & developments in flow cytometry techniques. Reagents & consumables are expected to emerge as the leading segment as they are essentials in flow cytometry analysis. In addition, combination of imaging capabilities and instruments further boost instrument performance and make it more accessible to emerging economies.

On the basis of technology, the bead-based flow cytometry segment is expected to exhibit the fastest growth, registering a CAGR of 8.6% from 2022 to 2031, owing to flow cytometry market trends like wide scale use of technology in research field, lesser time consumption, and simultaneous analysis of multiple samples. However, the cell-based flow cytometry segment is the highest revenue generating segment, owing to its wide scale application in the diagnosis of various diseases such as cancer and HIV, biomedical research, and its increasing use in monitoring the progress of drug treatment.

On the basis of application, academic & clinical applications segment accounted for a major share of the market share in the flow cytometry market in 2021, owing to increase in research of academic & clinical applications academic & clinical applications of flow cytometry. However, the diagnostic applications segment is expected to exhibit a prominent growth rate, owing to rise in use of technology in diagnostic applications.

On the basis of end user, the commercial organizations segment accounted for a major share of the market share in the flow cytometry market in 2021, owing to heavy investments in R&D activities, advancements in cell- and bead-based technologies, growing patient population, and increasing demand for flow cytometry in drug discovery process. This segment is expected to exhibit a prominent growth rate of 9.0%, owing to increase in novel clinical applications and immunoassay processes, and diversified applications of flow cytometry in diseases diagnosis.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/90

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By component, the reagents & consumables segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 10.5% from 2022 to 2031.
By technology, the bead-based flow cytometry segment is projected to grow at a CAGR of 8.6% during the forecast period.
By application, diagnostic applications segment is projected to grow at a CAGR of 8.5% during the forecast period.
By end user, the commercial organizations segment is projected to grow at a CAGR of 9.0% during the forecast period.
Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.6% during the forecast period.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.